Innovation in Clinical Trials: opportunities and challenges
|
|
- Alexander O’Connor’
- 6 years ago
- Views:
Transcription
1 Innovation in Clinical Trials: opportunities and challenges Enrica Andreoni Clinical Operations Country Study Manager, Roche SpA FROM - Bergamo - May 27 th, 2014
2 2 Empowered Patients Are Here
3 WHY Innovation in Clinical Research? 1. Take opportunities from new communication approaches (social media) 3
4 4 New Technologies Are Here
5 2. Take opportunities from new technologies Wearable biosensors/devices have the ability to objectively measure data that has traditionally been self reported by patients or required an office visit (e.g. sleep, activity, vital signs). Biosensors have the ability to provide an early intervention/coaching resulting in enhanced patient compliance and safety oversight in clinical trials. 5
6 Examples of opportunities from new technologies 6 but it is crucial to pay attention to data reliability and accuracy
7 7 Value Creation is Here, with the Shifting role of Government and Payers
8 8 3. Sustain new innovative medicines, developed with high quality in a timely manner and reducing costs
9 Personalized Medicine is Here 9
10 10 4. New technologies and new communication approaches could help us to reach easily and quickly our targeted patients for trials
11 Examples of Tools for Clinical Trial Innovation
12 12 Websites for Clinical Trials
13 Social Media & Patient Insights 13
14 14 Telemedicine & Mobile Home Nursing
15 15 Biosensors in Clinical Trials
16 16 Mobile Technology in Clinical Trials
17 Roche Innovation Overview Selected high impact initiatives Physician Insights Patient Insights Social Media Already available Obtain KOL insights quickly e.g. on identification of indications using online network Sermo Gain patient insights using networks such as Patients Like Me or Crohnology.com design studies which recruit faster Tools to support development of social media recruitment strategies that help accelerate recruitment Mobile Nurse Networks Sharing Trial Results to Patients Site Qualification Training Available in Q3/14 Mobile Nurses could reduce F2F trial visits and increase trial participation/ retention for patients unable to physically visit a trial site Share trial results with patients to foster trust and societal acceptance Establish mutual recognition of GCP training and site qualification between pharmaceutical companies Lean Protocol Design Decentralized Trial mhealth Experiments this year Design significantly more efficient and effective protocols - by starting with a bottoms up strategic firstprinciples approach Enable community doctors and their patients to participate in clinical trials using telemedicine Enable efficient, faster & costeffective development and deployment of mobile app solutions for study teams
18 Join efforts to improve Clinical Research: TransCelerate 18
19 19 TransCelerate Mission
20 TransCelerate ongoing Initiatives 20
21 Summary: Drug Development Needs Rethink the process increasing patients awareness and patients voice Decreasing costs Apply new technologies New communication approaches (social media) 21 Prepare the ground to accept
22 Clinical Research Innovation Challenges Tools: reliability & sensitivity Privacy law: differences country by country Regulatory aspects: EMA, FDA, country by country 22
23 Present & Future Prepare the ground to accept the changes Cultural aspects Regulatory implications Ethics/administrative implication Legal implications (i.e. privacy, advertising, ) Pilot Projects 23
24 Dream big and make possible! Innovation in clinical trials is a challenging need Innovation is helpful for patients, caregivers, physicians, pharmaceutical companies and governments Innovation could decrease drug development and health assistance costs Innovation means updating regulatory framework preserving three key important topics: 24 PATIENT S SECURITY PATIENT S PRIVACY PATIENT S QUALITY OF DATA
25 25 Thank you for your attention!
26 Doing now what patients need next 26
Why do we need an addendum to ICH E6?
Addendum to ICH E6 Hideaki Ui, Ph.D. Inspection Director Office of Non-clinical and Clinical Compliance Pharmaceuticals and Medical Devices Agency, Japan Disclaimer The views and opinions expressed in
More informationThe Outcome. Emerging Technologies in Healthcare. Dispatch From a Broken Healthcare System. How it Should Have Worked 11/12/17.
Emerging Technologies in Healthcare John Halamka Dispatch From a Broken Healthcare System On September 1, 2017, Kathy Halamka receives the following letter from Harvard Pilgrim Healthcare (the #1 HMO in
More informationIMPROVING YOUR CLINICAL TRIAL & ENHANCING THE PATIENT EXPERIENCE
ebook IMPROVING YOUR CLINICAL TRIAL & ENHANCING THE PATIENT EXPERIENCE Applying a patient-centered approach to enhance clinical trial performance, improve data quality, and ensure safety and efficacy.
More informationPATIENT RECRUITMENT & RETENTION
PATIENT RECRUITMENT & RETENTION» Start Strong» Get Back On Track» Inform and Engage Patients» Drive Site Performance Patient recruitment and retention isn t about numbers. It s about making and maintaining
More informationAddendum to ICH E6 (R2)
Addendum to ICH E6 (R2) Stephanie Shapley (US FDA) - Rapporteur Dr. Fergus Sweeney (EMA) - Regulatory Chair Date: December 15, 2015 International Council for Harmonisation of Technical Requirements for
More informationOFFICE FOR RESEACH PROCEDURE. Documentation of Investigational Site Qualifications, Adequacy of Resources and Training Records
OFFICE FOR RESEACH PROCEDURE Documentation of Investigational Site Qualifications, Adequacy of Resources and Training Records 1. Purpose: To describe the procedures related to the appropriate documentation
More informationPatient First Drug Development:
Patient First Drug Development: Exploring the patient perspective M-CERSI Bethesda March 9, 2015 Tom Murphy, PatientsLikeMe member & PALS Advocate Sally Okun, VP Advocacy, Policy & Patient Safety mir.
More informationOverview ICH GCP E6(R2) Integrated Addendum
2017 Biomedical Research Alliance of New York LLC CITI Program is a division of BRANY Overview ICH GCP E6(R2) Integrated Addendum Introduction On 15 December 2016, the International Council for Harmonistion
More informationGuidelines for Telemedicine Scheduling and Patient Care Co-ordination
Guidelines for Telemedicine Scheduling and Patient Care Co-ordination Content Overview Introduction to Scheduling and Patient Care Coordination 2 Model 1: Healthcare Provider Managed Scheduling and Patient
More informationFull Solution Logo. Perioperative Documentation Solution
Full Solution Logo Perioperative Documentation Solution Full Solution Logo Perioperative Documentation Solution AORN Syntegrity is an evidence-based perioperative documentation solution built by perioperative
More informationTechnologies in Pharmacology
Technologies in Pharmacology OBJECTIVES/RATIONALE Modern health care is increasingly dependent upon technology. Health care workers must be able to select appropriate equipment and instruments and use
More information19/09/2017. Telehealth Legal and Regulatory Issues in Colorado and Beyond. Nathaniel Lacktman, October 2017
Telehealth Legal and Regulatory Issues in Colorado and Beyond Nathaniel Lacktman, Esq. @Lacktman October 2017 1 2 1 Licensing 3 Licensing Physician offering care via telemedicine is subject to licensure
More informationDriving Business Value for Healthcare Through Unified Communications
Driving Business Value for Healthcare Through Unified Communications Even the healthcare sector is turning to technology to take a 'connected' approach, as organizations align technology and operational
More informationResearch Audits PGR. Effective: 12/04/2013 Reviewed: 12/04/2015. Name of Associated Policy: Palmetto Health Administrative Research Review
Effective: 12/04/2013 Reviewed: 12/04/2015 Name of Associated Policy: Palmetto Health Administrative Research Review Definitions Responsible Positions Equipment Needed Procedure Steps, Guidelines, Rules,
More informationRoles & Responsibilities of Investigator & IRB
Roles & Responsibilities of Investigator & IRB Jaranit Kaewkungwal Mahidol University Regulatory & Guidelines Regulatory & Guidelines GCP & Computer / Database Management Systems International Conference
More informationPersonal Experience Outcomes and the PEONIES Project: A brief introduction
Personal Experience Outcomes and the PEONIES Project: A brief introduction Introduction This brief overview will introduce you to: Personal Experience Outcomes The PEONIES Project Ways that PEONIES can
More informationTraining components for GCP. inspectors in PMDA. Tomonori Tateishi, MD, PhD Office of Conformity Audit, PMDA
Training components for GCP inspectors in PMDA Tomonori Tateishi, MD, PhD Office of Conformity Audit, PMDA Content 1. Conformity inspection in the training program for newcomers to PMDA 2. The training
More informationDr. R. Sathianathan. Role & Responsibilities of Principal Investigators in Clinical Trials. 18 August 2015
18 August 2015 Role & Responsibilities of Principal Dr. R. Sathianathan Professor of Psychiatry, SRMC, Porur & Former Director, Institute of Mental Health, Chennai Principal Investigators & GOOD CLINICAL
More informationEMERGING TRENDS WHAT I WILL COVER INCREASED INTEREST DEVICES ARE MIGRATING SAFE AND RELIABLE DEVICES LEAD TO LIVING WELL
SAFE AND RELIABLE DEVICES LEAD TO LIVING WELL THE HOME AND MEDICAL DEVICE TECHNOLOGY Presented by Mary Weick-Brady, MSN, RN April 20, 2012 Great Lakes Biomedical Conference on Home and Mobile Health WHAT
More informationIntegrated Leadership for Hospitals and Health Systems: Principles for Success
Integrated Leadership for Hospitals and Health Systems: Principles for Success In the current healthcare environment, there are many forces, both internal and external, that require some physicians and
More informationClinical Research Professionals
Training & Resources for Clinical Research Professionals Course & Publications Catalog January July 2016 In-Person and Web-Based Training Courses, Customized Training, elearning and Publications for Clinical
More informationRecruiting subjects for clinical research outside the academic setting
Recruiting subjects for clinical research outside the academic setting Laura A. Siminoff, PhD Professor & Chair Department of Social & Behavioral Health Virginia Commonwealth University Why recruit outside
More informationInvestigator-Initiated Studies: When you re the Sponsor. Cheri Robert & Tammy Mah-Fraser
Investigator-Initiated Studies: When you re the Sponsor Cheri Robert & Tammy Mah-Fraser ACRC Clinical Research Conference Edmonton, AB October 15, 2014 Session Objectives Define roles of the investigator,
More informationPablo Tebas, M.D. Joseph Quinn, RN, BSN Yan Jiang, RN, BSN, MSN
Gilead Sciences, Inc. / Protocol Number GS-US-380-1489 Page 1 of 9 PARTNER PREGNANCY FOLLOW UP CONSENT FORM Sponsor / Study Title: Protocol Number: Principal Investigator: (Study Doctor) Gilead Sciences,
More informationGuidance for Investigators Subject Recruitment & Retention
Guidance for Investigators Subject Recruitment & Retention Meeting of Investigators supported by the NHLBI Clinical Trials Planning Studies for Rare Thrombotic and Hemostatic Disorders (U34) program Sreelatha
More informationVertex Investigator-Initiated Studies Program Overview
Vertex Investigator-Initiated Studies Program Overview Our Goal Our Investigator Initiated Study grants support independent, investigator-initiated research designed to advance scientific knowledge of
More informationTomoko OSAWA, Ph.D. Director for GCP Inspection Office of Conformity Audit PMDA, Japan
Tomoko OSAWA, Ph.D. Director for GCP Inspection Office of Conformity Audit PMDA, Japan The views presented in this presentation are those of the author and should not be understood or quoted as being made
More informationObjectives. By the end of this educational encounter, the clinician will be able to:
Resident s Rights WWW.RN.ORG Reviewed May, 2016, Expires May, 2018 Provider Information and Specifics available on our Website Unauthorized Distribution Prohibited 2016 RN.ORG, S.A., RN.ORG, LLC By Melissa
More informationCopyright 2015 PointClickCare. PointClickCare is a registered trademark.
Senior Living residents needs are growing faster than your budget. But you don t have to sacrifice your level of service and property investment to maintain healthy margins. In today s fast-paced world,
More informationResidents Rights. Objectives. Introduction
Residents Rights Objectives By the end of this educational encounter, the clinician will be able to: 1. Identify basic resident rights 2. Relate how resident rights impact daily nursing practice 3. Apply
More informationThe GCP Perspective on Study Monitoring
The GCP Perspective on Study Monitoring Heidi Judge, CCRP Sr. Clinical Trials Project Manager Clinical Trials Network and Institute Massachusetts General Hospital 1 Overview Monitoring Basics Who, What,
More informationEuropean CRO Federation
European CRO Federation The interface between Industry CRO and Clinical Trials Networks: Defining the Roles EMA, London, 22 March 2012 Dr. Martine Dehlinger-Kremer Vice President Global Regulatory Affairs,
More informationResearch themes for the pharmaceutical sector
CENTRE FOR THE HEALTH ECONOMY Research themes for the pharmaceutical sector Macquarie University s Centre for the Health Economy (MUCHE) was established to undertake innovative research on health, ageing
More informationSEEKING PATIENT PERSPECTIVES IN CLINICAL TRIAL DESIGN AMY FROMENT, GLOBAL FEASIBILITY OPERATIONS DIR THE PATIENT S VOICE 2017
SEEKING PATIENT PERSPECTIVES IN CLINICAL TRIAL DESIGN AMY FROMENT, GLOBAL FEASIBILITY OPERATIONS DIR THE PATIENT S VOICE 2017 IMPORTANT CONTEXT As a biopharmaceutical business, Amgen is a commercial entity.
More informationHow/Where Can we Convey the Notion that Clinical Trials are Relevant for Everyone and Thereby Enhance Delivery of Patient Care?
How/Where Can we Convey the Notion that Clinical Trials are Relevant for Everyone and Thereby Enhance Delivery of Patient Care? Dr. Mei Krishnasamy Executive Director of Cancer Nursing and Allied Health
More informationPersonalized Smart Health
Published in May 2016 By Robin Robinson Pharma s Role in Personalized Smart Health Copyright 2016 by PharmaLinx LLC As the use of smart health devices increases, so do opportunities for pharmaceutical
More informationThe Cost of a Misfiled Medical Document
: The Cost of a Misfiled Medical Document INTRODUCTION Misfiling of medical documents is a common problem in all types of medical practices. A document may be misfiled for a number of reasons, and each
More informationManaging Privacy Risk in Your Research and Development Enterprise. Sujata Dayal, Abbott Justin McCarthy, Pfizer
Managing Privacy Risk in Your Research and Development Enterprise Sujata Dayal, Abbott Justin McCarthy, Pfizer Why Privacy Matters Human subject data is extremely sensitive Access to data is critical to
More informationPersonalized Smart Health
Published in May 2016 By Robin Robinson Pharma s Role in Personalized Smart Health As the use of smart health devices increases, so do opportunities for pharmaceutical companies. New technologies are driving
More information4.2. Clinical Trial Monitor (or Monitor): The person responsible for monitoring the data on behalf of the sponsor or contract research organization.
SOP #: MON-101 Page: 1 of 6 1. POLICY STATEMENT: The DF/HCC understands that external sponsors are required to monitor the progress of clinical investigations and ensure appropriate research data collection
More informationQuality Assurance and Regulatory Compliance Office and USAMRIID FDA Risk Management. Carolyn Mentzer Chief, QARCO
Quality Assurance and Regulatory Compliance Office and USAMRIID FDA Risk Management Carolyn Mentzer Chief, QARCO 301-619-3422 Who We Are and What We Do USAMRIID s mission is to conduct basic and applied
More informationFirstNet Update. John Matovich, FirstNet Solution Consultant
FirstNet Update John Matovich, FirstNet Solution Consultant 2018 AT&T Intellectual Property. FirstNet, First Responder Network Authority, and FirstNet logo are registered trademarks and service marks of
More informationPatient Payment Check-Up
Patient Payment Check-Up SURVEY REPORT 2017 Attitudes and behavior among those billing for healthcare and those paying for it CONDUCTED BY 2017 Patient Payment Check-Up Report 1 Patient demand is ahead
More informationGeneral Administration GA STANDARD OPERATING PROCEDURE FOR Sponsor Responsibility and Delegation of Responsibility
General Administration GA 102.01 STANDARD OPERATING PROCEDURE FOR Sponsor Responsibility and Delegation of Responsibility Approval: Nancy Paris, MS, FACHE President and CEO (17 July 2014) (Signature and
More informationToward Greater Scientific Rigor
Toward Greater Scientific Rigor Good Clinical Practice (GCP) A NEW REQUIREMENT! The Center for Clinical & Translational Science 205.934.7442 ccts@uab.edu www.uab.edu/ccts @cctsnetwork The requirement:
More informationGood Documentation Practices. Human Subject Research. for
Good Documentation Practices for Human Subject Research Bridget M. Psicihulis, RHIA, CCRC Quality Improvement Unit Coordinator Human Research Protection Program Wheaton Franciscan Healthcare (last updated
More informationISO14155: 2011 Clinical investigation of medical devices for human subjects - Good Clinical Practice - ISO TC194 WG4 Madoka Murakami PMDA, Japan
ISO14155: 2011 Clinical investigation of medical devices for human subjects - Good Clinical Practice - ISO TC194 WG4 Madoka Murakami PMDA, Japan What is GCP? Good Clinical Practice (GCP) is an international
More informationStandard Operating Procedures
Clinical Monitoring and Site Verification Procedure Overview To define the standard procedures for preparation and documentation of site visits for clinical monitoring and spoke verification for any NETT
More informationIntroduction to the United States Food and Drug Administration (FDA) and FDA Inspection Process VOICE
Introduction to the United States Food and Drug Administration (FDA) and FDA Inspection Process VOICE 2011 MTN Annual Meeting March 27, 2011 Lisa Noguchi, MSN Donna Germuga, DAIDS, OCSO, RN, BSN Objectives
More informationVitalConnect. Saving lives and enhancing patient care through elegant healthcare solutions.
VitalConnect Saving lives and enhancing patient care through elegant healthcare solutions. The Vista Solution Continuous patient monitoring. Anytime, anywhere. The Vista Solution platform changes the way
More informationDigital Disruption meets Indian Healthcare-the role of IT in the transformation of the Indian healthcare system
Digital Disruption meets Indian Healthcare-the role of IT in the transformation of the Indian healthcare system Introduction While the Indian healthcare system has made important progress over the last
More informationHealth Technology Assessment (HTA) Good Practices & Principles FIFARMA, I. Government s cost containment measures: current status & issues
KeyPointsforDecisionMakers HealthTechnologyAssessment(HTA) refers to the scientific multidisciplinary field that addresses inatransparentandsystematicway theclinical,economic,organizational, social,legal,andethicalimpactsofa
More informationNew Ways of Working - How Cross-Boundary Collaboration is Transforming Business
New Ways of Working - How Cross-Boundary Collaboration is Transforming Business We work differently on a smarter planet We work from anywhere Your closest collaborators may be scattered around the globe
More information2017 Clinical Trials Data Library
2017 Clinical Trials Data Library Copyright 2017 CenterWatch. Identification to Activation: A One-Year Cycle Median Site Startup vs. Cycle Time by Selected Countries Number of Registered Studies with Posted
More informationCenter for Health and Technology Telehealth Education Program. Executive Overview
Executive Overview 1. Technology-Enabled Health Understand the rationale for the use of advanced IT in healthcare Identify elements of a technology-enabled health care system Learn of the legal, regulatory
More informationMarketing. Pharmaceutical Industry: Marketing Positions 445
Marketing Pharmaceutical Industry: Marketing Positions 445 Restricted Drug Distribution (1714) To oppose restricted drug distribution systems that (1) limit patient access to medications; (2) undermine
More informationKeeping Your Compliance Program in Pace with Rapidly Expanding TeleHealth Services
Keeping Your Compliance Program in Pace with Rapidly Expanding TeleHealth Services In April 1924, an imaginative cover for the magazine Radio News foreshadowed telemedicine in its depiction of a "radio
More informationRethinking Telemetry and Its Impact on Healthcare. Wireless technology that improves care and reduces costs
Rethinking Telemetry and Its Impact on Healthcare Wireless technology that improves care and reduces costs Thinking differently about telemetry. You know it better than anyone the challenge of improving
More informationTELEMEDICINE CART/ROBOT PATIENT PORTAL & APP WEARABLE/ MONITORING DEVICE
Dr. RUDAKEMWA E INTRODUCTION Digital healthcare often referred to as Telemedicine is the use of medical information exchanged from one site to another via electronic communications to improve a patient
More informationConducting Monitoring Visits for Investigator-Initiated Trials (IITs)
Conducting Monitoring Visits for Investigator-Initiated Trials (IITs) Clinical Research Coordinator Society (CRCS) Forum 25 July 2014 Xia Yu Clinical Research Associate Singapore Clinical Research Institute
More informationIntroduction Patient-Centered Outcomes Research Institute (PCORI)
2 Introduction The Patient-Centered Outcomes Research Institute (PCORI) is an independent, nonprofit health research organization authorized by the Patient Protection and Affordable Care Act of 2010. Its
More information10 Things To Know About
10 Things To Know About Nurse Call 100% Nurse Approved 10 Things to Know About Nurse Call in 2016 Nurse call systems have evolved. Today s nurse call systems provide front-line nurses with critical communications
More informationCenters for Medicare & Medicaid Services: Innovation Center New Direction
Centers for Medicare & Medicaid Services: Innovation Center New Direction I. Background One of the most important goals at CMS is fostering an affordable, accessible healthcare system that puts patients
More informationUNIVERSITY OF PENNSYLVANIA HEALTH SYSTEM
Gilead Sciences, Inc. GS-US-248-0123, Amendment 1, 19-JUN-2012 A Long Term Follow-up Registry Study of Subjects Who Did Not Achieve Sustained Virologic Response in Gilead-Sponsored Trials in Subjects with
More informationProposed amendments to the Marihuana for Medical Purposes Regulations
Proposed amendments to the Marihuana for Medical Purposes Regulations Submission in response to the Canada Gazette publication on the proposed amendments to the Marihuana for Medical Purposes Regulations
More informationEmerging Roles for Medical Transcription in the Electronic Health Record
Emerging Roles for Medical Transcription in the Electronic Health Record Peter Preziosi, PhD, CAE Health Care Compliance Association April 22, 2006 Purpose To set and uphold standards for education and
More informationClinical Study Risk Assessment
Clinical Study Risk Assessment Clinical S.O.P. No.: 19 Compiled by: Approved by: Review date: November 2016 DOCUMENT HISTORY Version Detail of purpose / change Author / edited number by 1.0 New SOP Shona
More informationRESEARCH SERVICE PROVIDER CLINICAL SUPPORT SERVICES HEALTH OUTCOMES SOLUTIONS
RESEARCH SERVICE PROVIDER CLINICAL SUPPORT SERVICES HEALTH OUTCOMES SOLUTIONS Reliability Efficiency Consistency BRACANE COMPANY, INC. IS A CONSULTANCY RESEARCH FIRM LOCATED IN HISTORIC DOWNTOWN PLANO,
More informationBetter Medical Device Data Yield Improved Care The benefits of a national evaluation system
A fact sheet from Aug 2016 Better Medical Device Data Yield Improved Care The benefits of a national evaluation system Overview The current system for evaluating implanted medical devices provides inadequate
More informationPharmacovigilance: The patient s Perspective. Souzi Makri Chairperson AGORA EUPATI Fellow Executive Secretary CYPLAR President ENFA
Pharmacovigilance: The patient s Perspective Souzi Makri Chairperson AGORA EUPATI Fellow Executive Secretary CYPLAR President ENFA Scope of presentation Why is Pharmacovigilance important for patients?
More informationDANA-FARBER / HARVARD CANCER CENTER POLICIES FOR HUMAN SUBJECT RESEARCH TITLE:
POLICY #: EDU-100 Page: 1 of 5 1. POLICY STATEMENT: Individuals who participate in research activities overseen by DF/HCC must satisfy specific training requirements in order to conduct human subject research.
More informationLatham & Watkins Corporate Department
Number 1133 January 27, 2011 Client Alert Latham & Watkins Corporate Department FDA Announces Actions Designed to Improve the 510(k) Premarket Clearance Process Importantly, however, the Agency s identified
More informationTake a Course of Action.
Take a Course of Action. When you choose RAPS Online University, you ll be on track to expand your regulatory knowledge and advance your career. Our comprehensive learning provides an immersive experience
More informationIRB review of international research. Pre-conference P1 FCPA 3 rd Party Due Diligence for Health Entities. Today
John Heldens, CIP, CCRP Director, UCSF Health Care Compliance Association 2011 Compliance Conference IRB review of international research Pre-conference P1 FCPA 3 rd Party Due Diligence for Health Entities
More informationValue Proposition of the VictoryaHome Project
Value Proposition of the VictoryaHome Project Gunn-Hilde Rotvold, Tromsø Telemedicine Consulting Stephen Von Rump, Giraff Technologies AB J. Artur Serrano, Norwegian Centre for Integrated Care and Telemedicine
More information2017 Oncology Insights
Cardinal Health Specialty Solutions 2017 Oncology Insights Views on Reimbursement, Access and Data from Specialty Physicians Nationwide A message from the President Joe DePinto On behalf of our team at
More informationGood Clinical Practice. Lisa de Blieck MPA CCRC Clinical Trials Coordination Center
Good Clinical Practice Lisa de Blieck MPA CCRC Clinical Trials Coordination Center Good Clinical Practice (GCP) An international standard for the design, conduct, performance, monitoring, auditing, recording,
More informationWORKING TOGETHER WITH PATIENT GROUPS
WORKING TOGETHER WITH PATIENT GROUPS September 2017 Developed by the EFPIA Patient Think Tank 1 FOREWORD Europe is facing significant healthcare challenges due to an ageing population and increased prevalence
More informationSetting up a CITI account for users not enrolled at or employed by Georgia Tech. Georgia Institute of Technology December 2016
Setting up a CITI account for users not enrolled at or employed by Georgia Tech Georgia Institute of Technology December 2016 www.citiprogam.org Select REGISTER to establish an account. Affiliate with
More informationTraining & Resources for Clinical Research Professionals
a division of Cambridge Healthtech Institute Training & Resources for Clinical Research Professionals Course & Publications Catalog January July 2013 In-Person and Web-Based Training Courses, Customized
More informationRt hon Jeremy Hunt MP Secretary of State for Health and Social Care. Letter by to Dear Jeremy
Health and Social Care Committee House of Commons London SW1A 0AA Tel: 020 7219 6182 Fax 020 7219 5171 Email: hsccom@parliament.uk Website: www.parliament.uk/hsccom Twitter: @CommonsHealth From Dr Sarah
More informationWork plan for GCP Inspectors Working Group for 2018
22 March 2018 EMA/87812 /2018 Committees and Inspections Chairperson: Ana Rodriguez The activities outlined in the work plan for 2018 have been agreed in view of preparation for the Agency s relocation
More informationBig data in Healthcare what role for the EU? Learnings and recommendations from the European Health Parliament
Big data in Healthcare what role for the EU? Learnings and recommendations from the European Health Parliament Today the European Union (EU) is faced with several changes that may affect the sustainability
More informationMarch 31, Consumer Partnership for ehealth s Comments on the draft Shared Nationwide Interoperability Roadmap
March 31, 2015 By electronic mail Dr. Karen DeSalvo, M.D., M.P.H., M.Sc. National Coordinator for Health Information Technology U.S. Department of Health and Human Services 200 Independence Avenue SW,
More informationStandard Operating Procedures (SOP) Research and Development Office
Standard Operating Procedures (SOP) Research and Development Office Title of SOP: Maintaining Training Records SOP Number: 20 Version Number: 2.0 Supercedes: 1.0 Effective date: August 2013 Review date:
More informationLean startup in ehealth
Lean startup in ehealth 5/2015 Pauliina Smeds, Forum Virium Helsinki Jaakko Ikävalko, Forum Virium Helsinki The lean startup model aims at increasing the odds for success for startups, by reducing the
More informationLocal VA VA ORD CSP Other VA ORD. IRB of Record Registration Number: IRB Operated by: Local VA Non-local VA Academic Affiliate VHA Central IRB
ADMINISTRATIVE INFORMATION Principal Investigator: Study Coordinator: Protocol Title: Current Audit Date: Research Compliance Officer (RCO) or Designated Auditor(s): Local VA VA ORD CSP Other VA ORD Sponsor
More informationICH Regulators Forum. Dr Peter Arlett EU
Dr Peter Arlett EU International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use In this presentation ICH Regulators Forum: Background ICH Regulators
More informationLatin America: An Evolving Regulatory Environment September 15, Mapi 2015, All Rights Reserved
Latin America: An Evolving Regulatory Environment September 15, 2015 Mapi 2015, All Rights Reserved Upcoming Live Webinar Event: Key Information Featured Webinar Hosts Silvia Bendiner Director of Strategic
More informationCare Plan Management and Visit Verification Using ecare21 Mobile App.
Care Plan Management and Visit Verification Using ecare21 Mobile App. By Dr. Vadim Cherdak, PhD Anybody who had a chance to manage Homecare agency knows that the visit verification is a constant nightmare
More informationThe big-data revolution in US health care: Accelerating value and innovation
April 2013 The big-data revolution in US health care: Accelerating value and innovation Basel Kayyali, David Knott, and Steve Van Kuiken Big data could transform the health-care sector, but the industry
More informationBEST PRACTICES FOR DETERMINING FAIR MARKET VALUE FOR ALLIED HEALTH PROFESSIONAL SERVICES
BEST PRACTICES FOR DETERMINING FAIR MARKET VALUE FOR ALLIED HEALTH PROFESSIONAL SERVICES Presented at CBI conference: FMV of HCP and Investigator Payments May 20, 2015 AGENDA Section I Overview of the
More informationBefore the Federal Communications Commission Washington, D.C ) ) ) ) ) ) ) ) REPLY COMMENTS OF THE UNITED STATES TELECOM ASSOCIATION
Before the Federal Communications Commission Washington, D.C. 20554 In the Matter of Connect America Fund ETC Annual Reports and Certifications Rural Broadband Experiments WC Docket No. 10-90 WC Docket
More informationNICE Charter Who we are and what we do
NICE Charter 2017 Who we are and what we do 1. The National Institute for Health and Care Excellence (NICE) is the independent organisation responsible for providing evidence-based guidance on health and
More informationBig Data NLP for improved healthcare outcomes
Big Data NLP for improved healthcare outcomes A white paper Big Data NLP for improved healthcare outcomes Executive summary Shifting payment models based on quality and value are fueling the demand for
More informationGood Clinical Practice: A Ground Level View
Good Clinical Practice: A Ground Level View Jeanna Julo, BA, BA, CCRP Assistant Director, Clinical Data Management & Quality Controls, Auditing & Training Clinical Research Administration Research Institute,
More informationOffice of the Vice Chancellor for Research Supervisory Responsibilities of Clinical Investigators
Office of the Vice Chancellor for Research Supervisory Responsibilities of Clinical Investigators Patricia Fischer, RN, CCRP Investigator Responsibilities FDA Draft Guidance May 2007 Clarifies FDA s expectations,
More information7/18/2017. Malinda Peeples MS, RN, CDE VP Clinical Advocacy WellDoc Columbia, MD. Disclosure to Participants
Malinda Peeples MS, RN, CDE VP Clinical Advocacy WellDoc Columbia, MD Janice MacLeod MA, RDN, LDN, CDE Director Clinical Innovation WellDoc Columbia, MD Disclosure to Participants Notice of Requirements
More informationClinic Trial Coordinator
Date: February 2016 Job Title : Clinic Trial Coordinator Department : Haematology Location : North Shore & Waitakere Hospital Reporting To : Operationally to: Operations Manager Haematology Professionally
More informationApril 17, Edition of the Joint Commission International Accreditation. SUBJECT: MITA Feedback on the 5 th Standards for Hospitals
1300 North 17 th Street Suite 1752 Arlington, Virginia 22209 Tel: 703.841.3200 Fax: 703.841.3392 www.medicalimaging.org April 17, 2013 Paul vanostenberg, DDS, MS Vice President Accreditation and Standards
More information